Indeed, in breast cancer (Kymionis et al, 2001; Sjostrom et al, 2002) and thyroid carcinoma (Viale et al, 1995), Bcl-2 positivity also showed a favourable outcome. This evidence concerns the gene BCL2 and breast carcinoma.